Physician profile
Rose Susel
NPI 1851446751
$2,566.47
in general payments reported to CMS, 2019-2025
17 companies · $64.29 in 2025
The $64.29 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $38.55 · 2021: $158 · 2022: $244 · 2023: $830 · 2024: $1,077 · 2025: $64.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,971.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $672.69 | 2024 | M22 |
| Glaukos Corporation | $380.50 | 2023 | Kxl1b-Ce-Marked Kxlsystem, Kxl System (Refurbished) |
| Alcon Vision LLC | $353.78 | 2022-2025 | Total30, Precision7, Precision 1 |
| Bausch & Lomb Americas INC. | $242.21 | 2022-2025 | Infuse, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $190.37 | 2019-2021 | |
| Oyster Point Pharma, INC. | $150.49 | 2022-2023 | Tyrvaya |
| Lkc Technologies, INC. | $128.68 | 2023 | |
| Sun Pharmaceutical Industries INC. | $113.74 | 2022-2023 | Cequa |
| Optovue, INC. | $96.61 | 2019 | |
| Coopervision INC. | $46.96 | 2019 | |
| Sight Sciences, INC. | $46.09 | 2022-2024 | Tearcare System |
| Biotissue Holdings INC. | $38.67 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $35.89 | 2022-2023 | Acuvue |
| Novartis Pharmaceuticals Corporation | $20.71 | 2023 | |
| Abb Con-Cise Optical Group LLC | $17.48 | 2024 | Contact Lens, Spectacle Lenses |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Abbvie INC. | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rose Susel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.